Nomura Holdings Inc Aclaris Therapeutics, Inc. Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$9.74 - $17.92 $127,282 - $234,178	-13,068 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $605,708 - $912,758	-49,365 Reduced 79.07%	13,068 $190,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $2.38 Million - $3.34 Million	-177,800 Reduced 74.01%	62,433 $1.09 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $1.41 Million - $6.66 Million	240,233 New	240,233 $6.05 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.